Skura Announces Strategic Partnership With TargetRx
Online, May 2, 2011 (Newswire.com) - Skura Corporation, the leading provider of sales enablement solutions is pleased to announce a strategic partnership agreement with TargetRx and its innovative TargetAdvantage solution. The mutual goal of this exciting partnership is to provide pharmaceutical and biotech companies access to valuable physician-level information, to significantly improve physician targeting efforts, and to improve overall sales and marketing effectiveness.
"TargetAdvantage takes prescribing data to the next level, focusing not on what physicians did but why they did it. We feel strongly that this is a key component in effective targeting, which is why we're excited to team up with Skura. Their state-of-the-art Sales Enablement services reach a large number of clients that are serious about managing and nurturing interactions with customers. TargetAdvantage will add significantly to Skura's ability to deliver personalized content and ultimately improve customer relationships," Stated Craig Scott, CEO TargetRx.
"Our partnership with TargetRx represents a significant step forward in our goal to continually improve our Skura SFX users overall sales effectiveness." states Jeff Wessinger, President of Skura Corporation. "Enabling Skura SFX users with instant connectivity to the TargetRx solution and its wealth of information, in an easy to use and intuitive application, will undoubtedly strengthen the user relationships with their targeted physicians."
About TargetRx:
TargetRx provides pharmaceutical and biotech companies with unique insight into the true drivers of product choice and adoption for their brands, helping clients to confidently take the actions that will grow their businesses and help patients. Serving the majority of the top 30 pharmaceutical and biotech companies, TargetRx enables clients to significantly improve the launch of new products and indications, physician segmentation and targeting, creation of professional messaging and materials, and sales and marketing execution and effectiveness. All TargetRx solutions are powered by our AdvantageBuilderSM normative database and validated predictive models, created from capturing in-depth physician attitudes on the "four forces" of prescribing - product, payor, promotion and patient - on new launches, marketing campaigns and physician-rep interactions on over 500 pipeline and inline brands and modeling these attitudes against actual prescribing behavior. For more information, visit www.targetrx.com.
Share:
Tags: biotech, CLM, closed loop marketing, marketing effectiveness, Pharmaceutical, sales enablement, Skura SFX, TargetRx